KRAS, NRAS,BRAF mutation testing Doctors Abroad — Page 2

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Auala Hubert chairs the Gastrointestinal Cancer Center at Hadassah Medical Center. He uses KRAS, NRAS, and BRAF mutation testing to guide advanced cancer therapies.

• Holds specialist certifications in both medical oncology and radiotherapy
• Performs HIPEC – delivers heated chemotherapy directly into the abdominal cavity
• Member of the Israel Society of Clinical Oncology committee for gastrointestinal cancer
• Uses CyberKnife and Brachytherapy for precise tumor targeting
• Qualified in USMLE standards for medical practice

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Prof. Beni Boursi is a gastrointestinal oncology specialist at Sheba Medical Center. He uses KRAS, NRAS, and BRAF mutation testing for targeted therapy planning.

• Trained in oncology at the University of Pennsylvania and MD Anderson Cancer Center
• Academic scholar at the Perelman School of Medicine in the United States
• Published research on drug responses in patients with BRAF V600 mutations
• Member of the Israeli Association of Clinical Oncology and Radiotherapy
• Researches microbiome interactions to improve how patients respond to cancer treatments

Dr. Brenda Pastrana is a surgical oncologist at the JCI-accredited Galenia Hospital in Cancún. She specializes in breast, thyroid, and digestive system cancers. Dr. Pastrana is board-certified by CONACEM. She holds a medical degree from the Universidad Autónoma de México.

• Performs mastectomies, liver resections, and complex colon cancer surgeries.
• Treats patients at a facility holding Accreditation Canada Diamond Status.
• Serves as a university teacher at Universidad Anáhuac.
• Member of the Mexican Society of Oncology (SMEO).

Professor Eckhart Weidmann heads the hematology department at Nordwest Clinic. KRAS, NRAS, and BRAF mutation testing helps him determine precise therapy for blood disorders.

• Specializes in treating complex blood cancers and non-Hodgkin lymphoma
• Leads a dedicated department at a major German academic hospital
• Focuses on targeted therapies based on genetic mutation profiles
• Member of the German Society of Hematology and Medical Oncology (DGHO)

Dr. Elnur Sahibov is a specialist in radiation oncology at Emsey Hospital. He provides expertise in oncology services including KRAS, NRAS, and BRAF mutation testing.

• Trained at Marmara University Faculty of Medicine in radiation oncology
• Completed medical specialization between 2012 and 2016
• Graduated from the English-language medical program at Marmara University
• Practices at Emsey Hospital, a private multi-specialty center in Turkey

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries. He leads HCG Manavata Cancer Centre, where KRAS, NRAS, and BRAF mutation testing guides surgical planning.

• Completed surgical oncology residency at Tata Memorial Hospital in Mumbai
• Member of the Royal College of Surgeons of Edinburgh
• Participated in over 200 Phase 1–3 clinical trials
• Professor for DNB Superspecialty Surgical Oncology – training future cancer surgeons
• Treats complex cases of liver, pancreatic, and colorectal cancers

Dr. Lalit Banswal has performed 10,000 major surgeries. He uses KRAS, NRAS, and BRAF mutation testing to guide surgical treatment for gastrointestinal cancers.

• Fellowship-trained in surgical oncology at Tata Medical Centre in Kolkata
• Serves as Assistant Professor at the State Cancer Institute
• Specializes in robotic and laparoscopic surgery for colon and rectal cancers
• Experienced lead investigator for clinical research in gastrointestinal oncology
• Member of the surgical oncology team at HCG Manavata Cancer Centre

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre. He specializes in molecular oncology to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.

• Earned a DNB in Medical Oncology from the prestigious Indraprastha Apollo Hospital
• Presented stomach cancer research at the ASCO Gastrointestinal Cancer Symposium in San Francisco
• Member of the American Society of Clinical Oncology (ASCO)
• Former lecturer for the International Winter School of Oncology at AIIMS Bhopal
• Provides precision treatment for lung, breast, and gastrointestinal cancers